Janssens Sandrien, Anné Michael, Rombaut Patrick, Van den Mooter Guy
Laboratorium voor Farmacotechnologie en Biofarmacie, K.U. Leuven, Leuven, Belgium.
Eur J Pharm Sci. 2009 Jun 28;37(3-4):241-8. doi: 10.1016/j.ejps.2009.02.020. Epub 2009 Mar 13.
The presented study aims to explore the feasibility of preparing solid dispersions of the poorly soluble drug, itraconazole, with Kollicoat IR via spray drying, in order to broaden the application window of the polymer. In order to circumvent the need for a common solvent, Kollicoat IR was dissolved in a 50/50 (v/v) water/ethanol mixture and itraconazole was dissolved in a 50/50 (v/v) dichloromethane/ethanol mixture. In a first approach these two solutions were simultaneously spray dried via a spray nozzle with two inlets. In a second approach the two solutions were mixed prior to spray drying and the metastable solution was spray dried via a spray nozzle with a single inlet. This approach was also varied by adding HCl to the water phase of the Kollicoat IR solution. The resulting solid dispersions were characterized with MDSC, XRPD and their dissolution was followed in SGF. The results of the three data sets show that as the mixing between itraconazole and Kollicoat IR improves, the dissolution improves as well. Using the first approach, no mixing was observed between polymer and drug. The second approach on the other hand led to a reasonable degree of mixing as the solid dispersions were XRPD amorphous and no glassy mesofase of itraconazole was observed.
本研究旨在探索通过喷雾干燥法制备难溶性药物伊曲康唑与尤特奇IR固体分散体的可行性,以拓宽该聚合物的应用范围。为避免使用常用溶剂,尤特奇IR溶解于50/50(v/v)水/乙醇混合液中,伊曲康唑溶解于50/50(v/v)二氯甲烷/乙醇混合液中。第一种方法是通过具有两个入口的喷雾喷嘴将这两种溶液同时进行喷雾干燥。第二种方法是在喷雾干燥前将两种溶液混合,然后通过具有单个入口的喷雾喷嘴对亚稳溶液进行喷雾干燥。该方法还通过向尤特奇IR溶液的水相中添加盐酸而有所变化。所得固体分散体采用调制式差示扫描量热法(MDSC)、X射线粉末衍射(XRPD)进行表征,并在模拟胃液(SGF)中跟踪其溶出情况。三组数据集的结果表明,随着伊曲康唑与尤特奇IR之间混合程度的提高,溶出度也有所提高。采用第一种方法时,未观察到聚合物与药物之间的混合。另一方面,第二种方法导致了合理程度的混合,因为固体分散体的XRPD图谱为非晶态,且未观察到伊曲康唑的玻璃态中间相。